Breaking News

Alcami to Add HPAPI Capabilities

Two new cGMP production suites will focus on primary containment technologies at Germantown, WI facility

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Alcami plans to expand capabilities for the development and manufacture of Active Pharmaceutical Ingredients (APIs) at its Germantown, WI facility. The two new cGMP Highly Potent API (HPAPI) production suites will focus on primary containment technologies with engineering controls designed to meet the established Occupational Exposure Limit (OEL) of minimally 0.03 µg/m3 (SafeBridge Category 3). The 5,000 sq.-ft. renovation will be operational by 1Q17. The new space will include up to 150L rea...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters